In a nutshell Early-onset breast cancer rates in women under 40 vary significantly by location in the U.S., with a 32% ...

Lung cancer screening populations are older and sicker than those in the National Lung Screening Trial (NLST), a multicenter ...

Them’s the Brakes’ In the third episode of this season of “Yellowjackets,” the Wilderness is playing mind games, but so are ...

Doctors are hoping a clinical trial at Harris Health Ben Taub will prove the treatment works and it’s worth getting ...

Leaders at the Fred Hutch Cancer Center said the Trump administration's proposed NIH funding cuts would be "chilling, ...

Legal experts say the proposed cuts violate federal law and are unlikely to survive a legal challenge by states.

Last year was one of the most productive in the history of the Allen Institute for Artificial Intelligence (Ai2). Next up: translating all that work into real-world solutions.

Exelixis reaffirmed its 2025 sales guidance of $2.15-$2.25 billion and reported sustained long-term efficacy for Cabometyx in ...

Catch up on the biggest news and takeaways from AACR Annual Meeting 2025 — one of the most important gatherings in oncology.

Prostate cancer runs in Dean's family, and screening for it every year made it relatively straightforward to address. Now, he ...

The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...